Long-term oral tacrolimus in refractory to infliximab fistulizing Crohn's disease: Comments from Spanish experience - Reply

被引：0
|
作者：
Sandborn, WJ [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 03期
关键词：
D O I：
10.1053/j.gastro.2004.01.047
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：943 / 943
页数：1
相关论文
共 50 条
  • [21] Long-term durability of Crohn's disease treatment with infliximab
    Rudolph, Stephen J.
    Weinberg, David I.
    McCabe, Robert P.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (04) : 1033 - 1041
  • [22] Long-term outcomes of perianal fistulizing Crohn's disease in the biologic era
    Lee, Tanya
    Kamm, Michael A.
    Bell, Sally
    Lust, Mark
    Brown, Steve
    Niewiadomski, Ola
    Basnayake, Chamara
    Wright, Emily
    D'Souza, Basil
    Woods, Rodney
    Wei, Shu Chen
    Connell, William
    Thompson, Alexander
    Yong, Eric
    Ding, Nik Sheng
    JGH OPEN, 2021, 5 (02): : 235 - 241
  • [23] Long-term outcomes of seton drainage for perianal fistulizing Crohn's disease
    Banayan, E.
    Zagihyan, K.
    Fleshner, P.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S361 - S362
  • [24] Predictors of long-term radiological outcomes in perianal fistulizing Crohn's disease
    Lee, T.
    Kamm, M.
    Bell, S.
    Lust, M.
    Brown, S.
    Wright, E.
    Connell, W.
    Yong, E.
    Ding, N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 99 - 99
  • [25] Infliximab therapy for refractory Crohn's disease (CD) decreases the long-term need for bowel surgery
    Schnitzler, Fabian
    Fidder, Herma
    Ferrante, Marc
    Noman, Maja
    Van Assche, Gert A.
    Hoffman, Ilse
    Vermerie, Severine
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2008, 134 (04) : A134 - A134
  • [26] Long-term infliximab treatment in a patient with fistualizing Crohn's disease
    Wisniewska-Jarosinska, Maria
    Wichan, Pawel
    Chojnacki, Jan
    PRZEGLAD GASTROENTEROLOGICZNY, 2009, 4 (05): : 277 - 281
  • [27] Long-term outcome of Crohn's disease patients treated with infliximab
    Chen, B. L.
    Lv, S. C.
    Feng, T.
    Li, M. Y.
    Rao, P. S.
    Zeng, Z. R.
    Hu, P. J.
    Chen, M. H.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S245 - S245
  • [28] Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
    Baert, F
    Noman, M
    Vermeire, S
    Van Assche, G
    D'Haens, G
    Carbonez, A
    Rutgeerts, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07): : 601 - 608
  • [29] Long-term tacrolimus: A promising therapeutic approach for Crohn's disease
    Ierardi, E
    Principi, M
    Francavilla, R
    Pisani, A
    Rendina, M
    Panella, C
    Francavilla, A
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2107 - 2109
  • [30] Long-term outcomes of thalidomide in refractory Crohn's disease
    Gerich, M. E.
    Yoon, J. L.
    Targan, S. R.
    Ippoliti, A. F.
    Vasiliauskas, E. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) : 429 - 437
12345